A Study to Evaluate Two Different Regimens of VELCADE in Combination With Dexamethasone, Thalidomide and Cyclophosphamide (VDT vs VDTC) in Newly Diagnosed Multiple Myeloma

NCT00531453 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: bortezomib, dexamethasone, and thalidomide
DRUG: bortezomib, dexamethasone, thalidomide, and cyclophosphamide

Sponsor

Millennium Pharmaceuticals, Inc.

Collaborators

[object Object]